A Maryland woman is facing up to five years in prison after facing charges related to her giving the dangerous RU 486 abortion drug to a teenager. The teen reportedly took the abortion drug and experienced massive pain that hospitalized her and eventually killed her baby.
Sandra Craine, 62, was eventually charged related to giving the young girl the abortion bill but was not held responsible for the death of the unborn baby, according to the Cecil Whig newspaper:
Craine pleaded guilty to reckless endangerment on Dec. 16 in Cecil County Circuit Court as part of a plea agreement negotiated by Assistant State’s Attorney Kevin B. Urick and her Elkton-based defense lawyer, John Downs. In exchange for Craine’s guilty plea, prosecutors dropped a second-degree child abuse charge, which also related to the victim.
A Cecil County grand jury handed up the two-count indictment against Craine in August – about two months after she mail-ordered a packet of abortion pills, RU-486, off an overseas website and gave them to the victim, prosecutors reported. At the time, according to Urick, the teen was “20 weeks and five days” into her pregnancy.
Doctors who treated the pregnant teen at Union Hospital in Elkton told investigators and prosecutors that RU-486 must be taken during the first 10 weeks of pregnancy only, according to Urick.
“The packaging stated that a prescription was needed to obtain the medication and that it should be taken only under a doctor’s supervision,” Urick said. “The pills arrive in the mail and (Craine) gives the packet to (the victim). She takes her first pill on the morning of June 30 and two hours later, the pregnant (victim) is in Union Hospital with pain. Her baby was born alive a short time later, but died shortly thereafter.”
A report the FDA issued last April shows the deaths of and injuries to women from the dangerous RU 486 abortion drug continue to pile up while the Obama administration has done nothing to make the information available to women.
Following its approval during the Clinton administration, the FDA released a report in 2006 that received widespread attention for showing more than 1,100 women had been subjected to “adverse effects” resulting from their taking the abortion drug mifepristone, commonly known a RU 486. Pro-life advocates have waited five years for the FDA to come out with a new report of problems associated with the drug — despite mounting evidence that the abortion drug continues to kill and injure women across the globe.
The FDA, with no fanfare, released a new report, dated April 30, 2011. The report indicates 14 women in the United States alone have died from using the mifepristone abortion drug and 2,207 women have been injured by it.
Of the women experiencing medical and physical problems resulting from the abortion drug, 612 women required hospitalizations, 339 experienced blood loss significant enough to require a transfusion, 256 experienced infections and 48 women experienced what the FDA labeled as “severe infections.” Given that the RU 486 abortion drug caused sepsis, a potentially lethal infection that resulted in the deaths of women from around the world, the “serious infections” were very likely life-threatening situations.
“Severe infections generally involve death or hospitalization for at least 2-3 days, intravenous antibiotics for at least 24 hours, total antibiotic usage for at least 3 days, and any other physical or clinical findings, laboratory data or surgery that suggest a severe infection,” the FDA report states.
Women developing infections from usage of the RU 486 abortion drug experienced endometritis (involving the lining of the womb), pelvic inflammatory disease (involving the nearby reproductive organs such as the fallopian tubes or ovaries), and pelvic infections with sepsis (a serious systemic infection that has spread beyond the reproductive organs).
The FDA figures also reveal that abortion businesses like Planned Parenthood are still misusing the abortion drug.
Despite the FDA indicating, “Administration of mifepristone and misoprostol is contraindicated in patients with confirmed or suspected ectopic pregnancy (a pregnancy outside the uterus,” the abortion drug was given to women in 58 cases where they had an ectopic pregnancy.